Study Of An Investigational Drug For Prostate Cancer
Volunteers with advanced prostate cancer that has spread to their bones sought for a study of an investigational drug to assess if it stops the cancer from growing
4 Studies found
Cancer Research
Cancer Research
A Study Of An Investigational Drug, In Combination With Other Drugs, For Certain Types Of Prostate Cancer
Seeking men 18 years of age or older, for participation in a study of an investigational drug called Relugolix in combination with other drugs, for certain types of prostate cancer.
Cancer Research
An International Registry For Men With Advanced Prostate Cancer (Ironman)
IRONMAN Registry aims to collect detailed information about the participants in the study at the time of enrollment and to follow their medical care to better understand what treatments work and where there are unmet needs in their treatment.
Cancer Research
Study Of Ending Hormone Treatment After An Exceptional Response To Metastatic Prostate Cancer Hormone Treatment
Seeking men whose metastatic prostate cancer has responded exceptionally well to therapy that included a medication to decrease testosterone and a medication to prevent growth signals in the body from male hormones including testosterone for a study of interrupting hormone treatment to allow testosterone levels to recover.